ABL Diagnostics Société anonyme (EPA:ABLD)
France · Delayed Price · Currency is EUR 3.600
-0.080 (-2.17%)
At close: Feb 20, 2026
EPA:ABLD Market Cap
EPA:ABLD has a market cap or net worth of €58.01 million as of February 20, 2026. Its market cap has decreased by -18.18% in one year.
Market Cap
58.01M
Enterprise Value
59.78M
Revenue
6.23M
Ranking
n/a
PE Ratio
125.19
Stock Price
€3.60
Market Cap Chart
Since November 17, 2000, EPA:ABLD's market cap has increased from 2.51M to 58.01M, an increase of 2,212.91%. That is a compound annual growth rate of 13.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 58.01M | 20.00% |
| Dec 31, 2025 | 48.34M | 21.95% |
| Dec 31, 2024 | 39.64M | -74.64% |
| Dec 29, 2023 | 156.30M | 3,819.50% |
| Dec 30, 2021 | 3.99M | 34.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 110.27B |
| Sanofi | 96.10B |
| Sartorius Stedim Biotech | 17.78B |
| Ipsen | 12.95B |
| Eurofins-Cerep | 87.77M |
| Valerio Therapeutics Société anonyme | 73.08M |
| Klea Holding | 73.06M |
| THX Pharma Société Anonyme | 47.46M |